Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Clinical Drug Investigation|June 18, 2025
Association of Placebo Response with Effect Size in Randomized, Double-Blind Clinical Trials of Antidepressants in Children and Adolescents: A Systematic Review and Meta-analysisRisa Okubo, Kazuhiro Matsui, Mamoru NarukawaPharmaceutical Medicine|January 15, 2020
Evaluation of the Implementation of Additional Risk Minimization Activities in Europe, the USA, and JapanYuka Yasuoka, Masayuki Kaneko, Mamoru NarukawaJournal of Clinical Pharmacy and Therapeutics|December 18, 2019
Post-marketing safety-related regulatory actions on first-in-class drugs: A double-cohort studyJunji Ikeda, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|September 1, 2020
Pediatric Drug Development in Japan: A Comparison of the Current Situation and Characteristics Between Japan and EuropeEiji Ueyama, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|June 13, 2020
Characteristics of Drug Intervention Clinical Trials and Scientific Impact of the Trial Outcome: A Bibliometric Analysis Using the Relative Citation Ratio in Non-small Cell Lung Cancer from 2007 to 2016Yutaka Noguchi, Masayuki Kaneko, Mamoru NarukawaClinical Drug Investigation|May 24, 2023
Factors Related to Placebo Response in Randomized, Double-Blind Clinical Trials of Antidepressants in Children and Adolescents: A Meta-regression AnalysisRisa Okubo, Kazuhiro Matsui, Mamoru NarukawaClinical Pharmacology and Therapeutics|June 9, 2018
A Significant Anticancer Drug Approval Lag Between Japan and the United States Still Exists for Minor CancersKenji Yamashita, Masayuki Kaneko, Mamoru NarukawaLung|February 22, 2012
Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trialsKouichi Inoue, Mamoru Narukawa, Masahiro TakeuchiClinical Drug Investigation|October 21, 2019
Influence of Prevalent Vertebral Fracture on the Correlation between Change in Lumbar Spine Bone Mineral Density and Risk of New Vertebral Fracture: A Meta-Analysis of Randomized Clinical TrialsTsuyoshi Kobayashi, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|July 1, 2020
Factors Related to Conversion from Accelerated to Full Approval for Drugs Approved in the United States Between 2000 and 2016Koji Irisawa, Masayuki Kaneko, Mamoru NarukawaPageof 12